Literature DB >> 2454778

Tissue of origin of elevated alpha-fetoprotein in ataxia-telangiectasia.

T Ishiguro1, K Taketa, R A Gatti.   

Abstract

Although only a single gene exists for alpha-fetoprotein (AFP), differential glycosylation generates several different forms and these are associated with different tissues of origin, namely, liver, gastrointestinal tract, and yolk sac. This microheterogeneity of serum AFP was studied in seven patients with ataxia-telangiectasia (AT) in order to determine the tissue of origin of their elevated AFP levels. Concanavalin A (Con A), Lens culinaris agglutinin A (LCA-A), and erythroagglutinating phytohemagglutinin (E-PHA) affinity electrophoresis and antibody-affinity blotting were used to fractionate AFP. It was found that serum AFP in AT patients was composed mainly of Con-A band 2 (AFP-C2), LCA-A band 1 (AFP-L1), and E-PHA band 2 (AFP-P2). This profile of AFP species in AT patients is similar to those seen in neonates and patients with chronic hepatitis, but clearly different from AFP originating in hepatocellular carcinoma, gastric carcinoma, and yolk sac tumour cells. These data are compatible with a hepatic origin for the elevated AFP in AT patients. Since no evidence exists for ongoing liver damage in these patients, we suggest that the AFP gene in the AT liver may be under aberrant transcriptional control, perhaps secondary to a defect of DNA regulatory proteins which are necessary for hepatic maturation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2454778

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  5 in total

1.  Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia.

Authors:  S S Devgan; O Sanal; C Doil; K Nakamura; S A Nahas; K Pettijohn; J Bartek; C Lukas; J Lukas; R A Gatti
Journal:  Cell Death Differ       Date:  2011-03-11       Impact factor: 15.828

2.  Ataxia telangiectasia associated with nodular regenerative hyperplasia.

Authors:  Ki L Milligan; Karen Schirm; Stephanie Leonard; Ashleigh A Hussey; Anahita Agharahimi; David E Kleiner; Ivan Fuss; Shilpa Lingala; Theo Heller; Sergio D Rosenzweig
Journal:  J Clin Immunol       Date:  2016-09-26       Impact factor: 8.317

Review 3.  Protective Mechanisms Against DNA Replication Stress in the Nervous System.

Authors:  Clara Forrer Charlier; Rodrigo A P Martins
Journal:  Genes (Basel)       Date:  2020-06-30       Impact factor: 4.096

Review 4.  Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia.

Authors:  Shahrzad Bakhtiar; Sandra Woelke; Sabine Huenecke; Matthias Kieslich; Alexander Malcolm Taylor; Ralf Schubert; Stefan Zielen; Peter Bader
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

5.  Ataxia-Telangiectasia Presenting as Cerebral Palsy and Recurrent Wheezing: A Case Report.

Authors:  Marta Navratil; Vlasta Đuranović; Boro Nogalo; Alen Švigir; Iva Dumbović Dubravčić; Mirjana Turkalj
Journal:  Am J Case Rep       Date:  2015-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.